Exicon Co., Ltd. (KOSDAQ:092870)
29,600
+950 (3.32%)
At close: May 20, 2026
Exicon Revenue
In the year 2025, Exicon had annual revenue of 66.03B KRW with 108.87% growth. Exicon had revenue of 45.13B in the quarter ending December 31, 2025, with 251.26% growth.
Revenue
66.03B
Revenue Growth
+108.87%
P/S Ratio
5.96
Revenue / Employee
354.98M
Employees
n/a
Market Cap
393.83B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 66.03B | 34.42B | 108.87% |
| Dec 31, 2024 | 31.61B | -50.68B | -61.59% |
| Dec 31, 2023 | 82.30B | -8.86B | -9.72% |
| Dec 31, 2022 | 91.16B | 24.97B | 37.73% |
| Dec 31, 2021 | 66.19B | -1.23B | -1.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| LS SECURITIES | 2.09T |
| Sang-A Frontec | 195.99B |
| CYMECHS | 164.40B |
| Mecaro | 94.61B |
| ASTERASYS Co.,Ltd | 37.94B |
| Ecoeye | 30.92B |
| FutureChem Co.,Ltd | 18.67B |
| S.Biomedics | 16.55B |